Kanji Katayama

Dr. Kanji Katayama


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2007
Verified
Journal Article
Closed access
KKKenji Koneri
Kenji Koneri
TGTakanori Goi
Takanori Goi
YHYasuo Hirono
Yasuo Hirono
KKKanji Katayama
Kanji Katayama
AYAkio Yamaguchi
Akio Yamaguchi

19 August 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
DFDaisuke Fujimoto
Daisuke Fujimoto
YHYasuo Hirono
Yasuo Hirono
TGTakanori Goi
Takanori Goi
KKKanji Katayama
Kanji Katayama
SMShigeru Matsukawa
Shigeru Matsukawa
AYAkio Yamaguchi
Akio Yamaguchi
In addition to regulating platelet function, the G protein-coupled sub-family member Proteinase-activated receptor-1 (PAR1) has a proposed role in the development of various cancers, but its exact role and mechanism of action in the invasion, metastasis, and proliferation process in gastric cancer have yet to be completely elucidated. Here, we analyzed the relationship between PAR1 activation, proliferation, invasion, and the signaling pathways downstream of PAR1 activation in gastric cancer.

17 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YYYutaka Yonemura
Yutaka Yonemura
HIHaruaki Ishibashi
Haruaki Ishibashi
AMAkiyoshi Mizumoto
Akiyoshi Mizumoto
GTGorou Tukiyama
Gorou Tukiyama
YLYang Liu
Yang Liu
MMMasahiro Miura
Masahiro Miura
In the present article, we describe the normal structure of the peritoneum and review the mechanisms of peritoneal metastasis (PM) from gastric cancer (GC). The structure of the peritoneum was studied by a double-enzyme staining method using alkaline-phosphatase and 5′-nucreotidase, scanning electron microscopy, and immunohistological methods. The fundamental structure consists of three layers, mesothelial cells and a basement membrane (layer 1), macula cribriformis (MC) (layer 2), and submesothelial connective tissue containing blood vessels and initial lymphatic vessels, attached to holes in the MC (layer 3). Macro molecules and macrophages migrate from mesothelial stomata to the initial lymphatic vessels through holes in the MC. These structures are characteristically found in the diaphragm, omentum, paracolic gutter, pelvic peritoneum, and falciform ligament. The first step of PM is spillage of cancer cells (peritoneal free cancer cells; PFCCs) into the peritoneal cavity from the serosal surface of the primary tumor or cancer cell contamination from lymphatic and blood vessels torn during surgical procedures. After PFCCs adhere to the peritoneal surface, PMs form by three processes, i.e., (1) trans-mesothelial metastasis, (2) trans-lymphatic metastasis, and (3) superficial growing metastasis. Because the intraperitoneal (IP) dose intensity is significantly higher when generated by IP chemotherapy than by systemic chemotherapy, IP chemotherapy has a great role in the treatment of PFCCs, superficial growing metastasis, trans-lymphatic metastasis and in the early stages of trans-mesothelial metastasis. However, an established trans-mesothelial metastasis has its own interstitial tissue and vasculature which generate high interstitial pressure. Accordingly, it is reasonable to treat established trans-mesothelial metastasis by bidirectional chemotherapy from both IP and systemic chemotherapy.


26 November 2016 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MMMakoto Murakami
Makoto Murakami
KKKanji Katayama
Kanji Katayama
SKShigeru Kato
Shigeru Kato
DFDaisuke Fujimoto
Daisuke Fujimoto
MMMitsuhiro Morikawa
Mitsuhiro Morikawa
TGTakanori Goi
Takanori Goi
Large-cell neuroendocrine carcinoma (LCNEC) of the bile duct is extremely rare and is a high-grade type of neuroendocrine tumor with an aggressive clinical course. Here, we report a case of LCNEC of the extrahepatic bile duct. An 80-year-old man presented with severe jaundice. Endoscopic retrograde cholangiography and enhanced computed tomography revealed complete obstruction of the common bile duct (CBD) by a dense tumor measuring 1.5 cm in diameter. Although there were no malignant cells in the biliary brush cytology, we suspected a cholangiocarcinoma and performed extrahepatic bile duct resection. Histologically, the LCNEC occupied most of the places deeper than the stratum submucosum and an adenocarcinoma component, approximately 15%, was present in the mucosa. There were no transitional areas between the two components. Immunohistochemically, the LCNEC cells were reactive for CD56 and synaptophysin and had a high MIB-1 index (72%). The patient died of multiple liver, lung, and peritoneal metastases 3 months after surgery. LCNEC of the CBD is particularly rare and has a very poor prognosis. Only five cases have been reported in the literature; therefore, there is no established effective therapy, including surgery, for LCNEC of the CBD at present. An accumulation of additional cases and further studies of multimodal treatment are required in the future to improve the prognosis.

1 May 2013
Verified
Journal Article
Closed access
SOShinsuke Obata
Shinsuke Obata
TGTakanori Goi
Takanori Goi
TNToshiyuki Nakazawa
Toshiyuki Nakazawa
YKYouhei Kimura
Youhei Kimura
KKKanji Katayama
Kanji Katayama
AYAkio Yamaguchi
Akio Yamaguchi